Microglia in animal models of autism spectrum disorders

被引:9
|
作者
Andoh, Megumi [1 ]
Ikegaya, Yuji [1 ]
Koyama, Ryuta [1 ]
机构
[1] Univ Tokyo, Grad Sch Pharmaceut Sci, Chem Pharmacol Lab, Bunkyo Ku, Tokyo, Japan
来源
AUTISM | 2020年 / 173卷
关键词
MATERNAL IMMUNE ACTIVATION; WILD-TYPE MICROGLIA; MOUSE MODEL; SOCIAL-INTERACTION; BRAIN-DEVELOPMENT; VALPROIC ACID; BEHAVIOR; MICE; RATS; STRESS;
D O I
10.1016/bs.pmbts.2020.04.012
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Various genetic and environmental factors have been suggested to cause autism spectrum disorders (ASDs). A variety of animal models of ASDs have been developed and used to investigate the mechanisms underlying the pathogenesis of ASDs. These animal models have contributed to clarifying that abnormalities in neuronal morphology and neurotransmission are responsible for the onset of ASDs. In recent years, researchers have started to focus not only on neurons but also on glial cells, particularly microglia. This is because microglial malfunction is strongly associated with structural and functional abnormalities of neurons, as well as the inflammation that is commonly observed both in the brains of patients with ASDs and in animal models of ASDs. In this chapter, we first introduce a list of commonly available animal models of ASDs and describe the validity of each model from the viewpoint of behaviors and neuroanatomy. We next detail the malfunction of microglia that has been reported in animal models of ASDs and discuss the roles of microglia in ASD pathogenesis. We will further propose possible therapeutic strategies to tackle ASDs by controlling microglial functions.
引用
收藏
页码:239 / 273
页数:35
相关论文
共 50 条
  • [21] Cerebellar and Striatal Implications in Autism Spectrum Disorders: From Clinical Observations to Animal Models
    Thabault, Mathieu
    Turpin, Valentine
    Maisterrena, Alexandre
    Jaber, Mohamed
    Egloff, Matthieu
    Galvan, Laurie
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (04)
  • [22] Rho GTPase Regulators and Effectors in Autism Spectrum Disorders: Animal Models and Insights for Therapeutics
    Guo, Daji
    Yang, Xiaoman
    Shi, Lei
    CELLS, 2020, 9 (04)
  • [23] Autism spectrum disorder: neuropathology and animal models
    Varghese, Merina
    Keshav, Neha
    Jacot-Descombes, Sarah
    Warda, Tahia
    Wicinski, Bridget
    Dickstein, Dara L.
    Harony-Nicolas, Hala
    De Rubeis, Silvia
    Drapeau, Elodie
    Buxbaum, Joseph D.
    Hof, Patrick R.
    ACTA NEUROPATHOLOGICA, 2017, 134 (04) : 537 - 566
  • [24] Autism spectrum disorder: neuropathology and animal models
    Merina Varghese
    Neha Keshav
    Sarah Jacot-Descombes
    Tahia Warda
    Bridget Wicinski
    Dara L. Dickstein
    Hala Harony-Nicolas
    Silvia De Rubeis
    Elodie Drapeau
    Joseph D. Buxbaum
    Patrick R. Hof
    Acta Neuropathologica, 2017, 134 : 537 - 566
  • [25] Oxytocin in animal models of autism spectrum disorder
    Penagarikano, Olga
    DEVELOPMENTAL NEUROBIOLOGY, 2017, 77 (02) : 202 - 213
  • [26] Mutant mouse models of autism spectrum disorders
    Provenzano, Giovanni
    Zunino, Giulia
    Genovesi, Sacha
    Sgado, Paola
    Bozzi, Yuri
    DISEASE MARKERS, 2012, 33 (05) : 225 - 239
  • [27] Overview of genetic models of autism spectrum disorders
    Patel, Jheel
    Lukkes, Jodi L.
    Shekhar, Anantha
    GENETIC MODELS AND MOLECULAR PATHWAYS UNDERLYING AUTISM SPECTRUM DISORDERS, 2018, 241 : 1 - 36
  • [28] The utility of rodent models of autism spectrum disorders
    Lazaro, Maria T.
    Golshani, Peyman
    CURRENT OPINION IN NEUROLOGY, 2015, 28 (02) : 103 - 109
  • [29] Neuritogenic function of microglia in maternal immune activation and autism spectrum disorders
    Srinidhi Venkatesan Kalavai
    Seiko Ikezu
    Neural Regeneration Research, 2021, 16 (07) : 1436 - 1437
  • [30] Neuritogenic function of microglia in maternal immune activation and autism spectrum disorders
    Kalavai, Srinidhi Venkatesan
    Ikezu, Seiko
    NEURAL REGENERATION RESEARCH, 2021, 16 (07) : 1436 - 1437